Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 23103440)

1.

Risk of vancomycin-induced nephrotoxicity in the population with chronic kidney disease.

Panwar B, Johnson VA, Patel M, Balkovetz DF.

Am J Med Sci. 2013 May;345(5):396-9. doi: 10.1097/MAJ.0b013e318268023d. Review.

PMID:
23103440
2.

Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.

Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A.

Eur J Clin Pharmacol. 2012 Sep;68(9):1243-55. doi: 10.1007/s00228-012-1259-9. Epub 2012 Mar 13. Review.

PMID:
22411630
3.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.

Clin Ther. 2012 Jan;34(1):149-57. doi: 10.1016/j.clinthera.2011.12.013.

PMID:
22284995
4.

Vancomycin nephrotoxicity: myths and facts.

Gupta A, Biyani M, Khaira A.

Neth J Med. 2011 Sep;69(9):379-83. Review.

5.

Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.

Ramírez E, Jiménez C, Borobia AM, Tong HY, Medrano N, Krauel-Bidwell L, Carcas AJ, Selgas R, Frías J.

Ther Drug Monit. 2013 Jun;35(3):360-6. doi: 10.1097/FTD.0b013e318286eb86.

PMID:
23666575
6.

High-dose intravenous vancomycin therapy and the risk of nephrotoxicity.

Rostas SE, Kubiak DW, Calderwood MS.

Clin Ther. 2014 Jul 1;36(7):1098-101. doi: 10.1016/j.clinthera.2014.05.011. Epub 2014 Jun 13.

PMID:
24931573
7.

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Hazlewood KA, Brouse SD, Pitcher WD, Hall RG.

Am J Med. 2010 Feb;123(2):182.e1-7. doi: 10.1016/j.amjmed.2009.05.031. Review.

8.

Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Shen WC, Chiang YC, Chen HY, Chen TH, Yu FL, Tang CH, Sue YM.

Nephrology (Carlton). 2011 Nov;16(8):697-703. doi: 10.1111/j.1440-1797.2011.01488.x.

PMID:
21707841
9.

Risk factors for acute kidney injury in adult patients receiving vancomycin.

Cappelletty D, Jablonski A, Jung R.

Clin Drug Investig. 2014 Mar;34(3):189-93. doi: 10.1007/s40261-013-0163-0.

PMID:
24385282
10.

Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter.

van Hal SJ, Paterson DL, Lodise TP.

Antimicrob Agents Chemother. 2013 Feb;57(2):734-44. doi: 10.1128/AAC.01568-12. Epub 2012 Nov 19. Review.

11.

Recent changes in vancomycin use in renal failure.

Vandecasteele SJ, De Vriese AS.

Kidney Int. 2010 May;77(9):760-4. doi: 10.1038/ki.2010.35. Epub 2010 Feb 24. Review.

PMID:
20182415
12.

Chronic kidney disease following acute kidney injury-risk and outcomes.

Leung KC, Tonelli M, James MT.

Nat Rev Nephrol. 2013 Feb;9(2):77-85. doi: 10.1038/nrneph.2012.280. Epub 2012 Dec 18. Review.

PMID:
23247572
13.
14.
15.

Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.

Pritchard L, Baker C, Leggett J, Sehdev P, Brown A, Bayley KB.

Am J Med. 2010 Dec;123(12):1143-9. doi: 10.1016/j.amjmed.2010.07.025.

PMID:
21183005
16.

Kidney diseases in Africa: aetiological considerations, peculiarities and burden.

Okunola O, Akinsola A, Ayodele O.

Afr J Med Med Sci. 2012 Jun;41(2):119-33. Review.

PMID:
23185909
17.

Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.

McKamy S, Hernandez E, Jahng M, Moriwaki T, Deveikis A, Le J.

J Pediatr. 2011 Mar;158(3):422-6. doi: 10.1016/j.jpeds.2010.08.019.

PMID:
20888013
18.

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.

Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.

Arch Intern Med. 2006 Oct 23;166(19):2138-44.

PMID:
17060545
19.

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.

Wong-Beringer A, Joo J, Tse E, Beringer P.

Int J Antimicrob Agents. 2011 Feb;37(2):95-101. doi: 10.1016/j.ijantimicag.2010.10.013. Epub 2010 Dec 3. Review.

PMID:
21130609
20.

The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.

Horey A, Mergenhagen KA, Mattappallil A.

Ann Pharmacother. 2012 Nov;46(11):1477-83. doi: 10.1345/aph.1R158. Epub 2012 Oct 16.

PMID:
23073306
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk